Key Takeaways MIC B12 injections before and after results vary depending on the patients baseline B12 levels, metabolic health, and adherence to nutrition and activity plans
Contraindications for use B12 injections should not be administered to children or pregnant or breastfeeding women

According to British Society for Haematology (BSH) guidelines and NICE Clinical Knowledge Summaries (CKS), the primary beneficiaries include: Key patient groups who may require B12 injections include: Pernicious anaemia patients requiring lifelong hydroxocobalamin 1mg intramuscularly every 23 months following initial loading doses Patients with gastrointestinal disorders including those who have undergone gastrectomy or ileal resection, and patients with conditions affecting B12 absorption such as Crohn's disease or coeliac disease Strict vegans and vegetarians though oral supplementation is usually sufficient unless malabsorption is present Elderly patients who may have reduced gastric acid production affecting B12 absorption Patients taking certain medications including metformin (MHRA advises monitoring B12 levels in long-term users, particularly those with risk factors or symptoms), proton pump inhibitors, and H2-receptor antagonists long-term [6] Individuals with neurological symptoms such as paraesthesia, ataxia, or cognitive impairment related to B12 deficiency Pregnant women with confirmed deficiency (hydroxocobalamin for malabsorption

Mounjaro is primarily prescribed for type 2 diabetes and weight management but may offer additional benefits in the future as research continues
The changes promote conversion of stored fat into energy
Moreover, interferon-gamma (IFN) increases the expression of ZEB1 in a STAT1-JMJD3-dependent manner, thereby promoting the invasiveness of lung cancer cells [58,59,60]